Automated characterization of patient-ventilator interaction using surface electromyography.

Journal Information

Full Title: Ann Intensive Care

Abbreviation: Ann Intensive Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateInformed consent was obtained from patients or their legal representatives, and the study was approved by the local ethics committee (EA4/005/19) and registered with the German Clinical Trials Register (DRKS, DRKS00017138, 15 April 2019, https://drks.de/search/de/trial/DRKS00017138). Consent for publicationNot applicable. Competing interestsJG and PR hold multiple patents with Drägerwerk AG & Co. KGaA. JS, JG, NMC, and PR have received research grants from Drägerwerk AG & Co. KGaA. Competing interests JG and PR hold multiple patents with Drägerwerk AG & Co. KGaA. JS, JG, NMC, and PR have received research grants from Drägerwerk AG & Co. KGaA."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. The corresponding author was partially funded by the German Federal Ministry for Economic Affairs and Climate Action (BMWK) through the KI-SIGS Project (FKZ: 01MK20012B). JG and PR were partially funded by European Union—European Regional Development Fund, the Federal Government and Land Schleswig-Holstein through the project: Diagnose- und Therapieverfahren für die Individualisierte Medizintechnik (IMTE) (Project No. 12420002). The clinical study and data acquisition were partially funded by Drägerwerk AG & Co. KGaA."

Evidence found in paper:

"We included adult patients with ARDS, who were admitted to one of the participating intensive care units (ICU) at Charité – Universitätsmedizin Berlin, the tertiary care university hospital in Berlin, Germany. Patients were excluded if they had a preexisting lung condition that would significantly change lung mechanics (e.g., COPD GOLD 3-4, pulmonary fibrosis, cystic fibrosis), unfavorable prognosis with expected death within the following days, or pregnant or breastfeeding patients. Consent was obtained from the patient proxy or legal representative and from the patients themselves as soon as they could give consent. The study was approved by the local ethics committee (EA4/005/19) and registered at the German Clinical Trials Register (DRKS00017138). Declarations: Ethics approval and consent to participateInformed consent was obtained from patients or their legal representatives, and the study was approved by the local ethics committee (EA4/005/19) and registered with the German Clinical Trials Register (DRKS, DRKS00017138, 15 April 2019, https://drks.de/search/de/trial/DRKS00017138).: Consent for publicationNot applicable.: Competing interestsJG and PR hold multiple patents with Drägerwerk AG & Co. KGaA. JS, JG, NMC, and PR have received research grants from Drägerwerk AG & Co. KGaA. Ethics approval and consent to participate: Informed consent was obtained from patients or their legal representatives, and the study was approved by the local ethics committee (EA4/005/19) and registered with the German Clinical Trials Register (DRKS, DRKS00017138, 15 April 2019, https://drks.de/search/de/trial/DRKS00017138)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025